Corcept Therapeutics Inc financial data

Symbol
CORT on Nasdaq
Industry
Pharmaceutical Preparations
Location
149 Commonwealth Drive, Menlo Park, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 438 % -41.7%
Quick Ratio 7.04 % -25.6%
Debt-to-equity 23.7 % +62.2%
Return On Equity 24.4 % +25.5%
Return On Assets 19.7 % +16.3%
Operating Margin 23.3 % -4.31%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 104M shares +2.5%
Common Stock, Shares, Outstanding 103M shares -4.11%
Entity Public Float 1.83B USD -11.2%
Common Stock, Value, Issued 133K USD +2.31%
Weighted Average Number of Shares Outstanding, Basic 103M shares -4.72%
Weighted Average Number of Shares Outstanding, Diluted 110M shares -4.77%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 524M USD +26.5%
Research and Development Expense 202M USD +40.6%
Costs and Expenses 402M USD +28.3%
Operating Income (Loss) 122M USD +21.1%
Nonoperating Income (Expense) 19.2M USD +172%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 141M USD +30.9%
Income Tax Expense (Benefit) 23.1M USD +73.9%
Net Income (Loss) Attributable to Parent 118M USD +24.9%
Earnings Per Share, Basic 1.14 USD/shares +29.5%
Earnings Per Share, Diluted 1.05 USD/shares +29.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 150M USD -50.1%
Marketable Securities, Current 261M USD +58.1%
Accounts Receivable, after Allowance for Credit Loss, Current 61.5M USD +89%
Inventory, Net 7.19M USD +12.2%
Other Assets, Current 18.4M USD
Assets, Current 503M USD -5.72%
Deferred Income Tax Assets, Net 97.9M USD +43.9%
Property, Plant and Equipment, Net 127K USD -72.5%
Operating Lease, Right-of-Use Asset 61K USD -89.4%
Other Assets, Noncurrent 6.39M USD +34.1%
Assets 656M USD +6.16%
Accounts Payable, Current 12.6M USD +12%
Employee-related Liabilities, Current 25.5M USD +64.1%
Accrued Liabilities, Current 59.7M USD +52.8%
Liabilities, Current 97.2M USD +23.3%
Accrued Income Taxes, Noncurrent 10.9M USD +15.6%
Operating Lease, Liability, Noncurrent 552K USD
Liabilities 108M USD +22.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 258K USD
Retained Earnings (Accumulated Deficit) 430M USD +37.8%
Stockholders' Equity Attributable to Parent 548M USD +3.45%
Liabilities and Equity 656M USD +6.16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 23.8M USD -8.48%
Net Cash Provided by (Used in) Financing Activities -543K USD -400%
Net Cash Provided by (Used in) Investing Activities -9.01M USD -104%
Common Stock, Shares Authorized 280M shares 0%
Common Stock, Shares, Issued 134M shares +2.59%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 14.2M USD -93.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 150M USD -50.1%
Deferred Tax Assets, Valuation Allowance 15.9M USD +7.47%
Deferred Tax Assets, Gross 107M USD +39.2%
Operating Lease, Liability 76K USD -86.8%
Payments to Acquire Property, Plant, and Equipment 139K USD -66.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 118M USD +23.8%
Lessee, Operating Lease, Liability, to be Paid 77K USD -86.7%
Property, Plant and Equipment, Gross 4.48M USD +6.85%
Operating Lease, Liability, Current 76K USD -86.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 155K USD -86.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +100%
Deferred Income Tax Expense (Benefit) -7.16M USD -6.48%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -66.7%
Deferred Tax Assets, Operating Loss Carryforwards 3.94M USD -19.3%
Deferred Federal Income Tax Expense (Benefit) -25.6M USD +8.92%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 13M USD +14%
Operating Lease, Payments 2.43M USD +5.06%
Additional Paid in Capital 739M USD +11.5%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 7.59M USD -20.2%
Current Federal Tax Expense (Benefit) 40.3M USD +2.9%
Amortization of Intangible Assets 52K USD -56.3%
Depreciation, Depletion and Amortization 68K USD -60.5%
Deferred Tax Assets, Net of Valuation Allowance 90.6M USD +47.4%
Deferred State and Local Income Tax Expense (Benefit) -2.65M USD +50.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%